Critical Care

Nov 19 2024 117 ep. 43

Copy RSS

Subscribe on Podcast Addict

Mixed vs. Pure Soybean Oil Lipid Emulsions: How to Select and Monitor Patients

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Phil Ayers, PharmD, BCNSP, FMSHP, FASHP Though 100% soybean oil was once the standard for lipid emulsions in parenteral nutrition, mixed lipid emulsions have become more popular over the last decade. But there are a variety of patient-specific factors to consider before determining which type of lipid emulsion is appropriate.

Emerging Data on Reversal and Repletion for Anticoagulated Patients with ICH: The Neurocritical Care Perspective

Host: Natalie Kreitzer, MD, MS Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Thorsten Steiner, MD, PhD, MME Host: Adrian R. Parry-Jones, FRCP, PhD Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focu

Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH

Host: David Seiffge, MD Host: Natalie Kreitzer, MD, MS Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical

Neurosurgical Management of ICH: Making Sense of ENRICH, SWITCH, STICH and MISTIE

Host: Hiren C. Patel, PhD, FRCS Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Adrian R. Parry-Jones, FRCP, PhD Host: Thorsten Steiner, MD, PhD, MME Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data foc

ESO Guidelines for the Management of ICH in the Anticoagulated Patient

Host: Thorsten Steiner, MD, PhD, MME Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: David Seiffge, MD Host: Adrian R. Parry-Jones, FRCP, PhD Host: Natalie Kreitzer, MD, MS Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches,

Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?

Host: Adrian R. Parry-Jones, FRCP, PhD Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Hiren C. Patel, PhD, FRCS Host: David Seiffge, MD Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on rever

Audience Q&A with Panel

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Natalie Kreitzer, MD, MS Host: Adrian R. Parry-Jones, FRCP, PhD Host: Hiren C. Patel, PhD, FRCS Host: David Seiffge, MD Host: Thorsten Steiner, MD, PhD, MME Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights in

Navigating the Crisis: How to Diagnose and Treat Malignant Hyperthermia

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Henry Rosenberg, MD Malignant hyperthermia is an inherited disorder primarily recognized by anesthesia professionals. And since this condition can have significant consequences on a patient’s health, including their likelihood of surviving surgery, it’s important to know how to diagnose and treat malignant hyperthermia em

Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Natalie Kreitzer, MD, MS Host: Adrian R. Parry-Jones, FRCP, PhD Host: Rhonda Cadena, MD, FNCS, FCCM Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on antico

Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Rhonda Cadena, MD, FNCS, FCCM Host: Adrian R. Parry-Jones, FRCP, PhD Host: Stuart Connolly, MD, FRCPC Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anti